GLP-1 and CKD safety considerations Some studies have found people living with CKD, particularly those in advanced stages or kidney failure, are more likely to experience gastrointestinal side effects from GLP-1s
If the weight management indication is denied, your clinician may explore the cardiovascular indication (Wegovy) or the sleep apnea indication (Zepbound) if clinically appropriate
Under the JV, Sigma will licence the Chemist Warehouse brand and intellectual property, and provide retail support, including ranging, store layout, inventory management and marketing support
Offers a clean interface for calculating BAC water volumes and syringe units
If you want to continue GLP-1 therapy, you'll likely need to switch to a brand-name GLP-1
Antibodies against -Actin (sc-47778) and CIAP1 (sc-7943) were purchased from Santa Cruz Biotechnology (Dallas, Texas, USA)